Clinical Trial Update: Plasma Dipeptidyl-peptidase-4 Activities With No-reflow and Bleeding

View source ↗

Summary

A completed clinical trial evaluating plasma dipeptidyl-peptidase-4 activities in STEMI patients undergoing PCI, with focus on no-reflow and bleeding.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Dipeptidyl-peptidase-4, STEMI | Status: COMPLETED